Evidence map›Paper›PMID 31398874›Full record

ArticleInternational journal of molecular sciences2019

Versatile Biomaterial Platform Enriched with Graphene Oxide and Carbon Nanotubes for Multiple Tissue Engineering Applications.

Simona-Rebeca Ignat, Andreea Daniela Lazăr, Aida Şelaru, Iuliana Samoilă, George Mihail Vlăsceanu, Mariana Ioniţă, Eugen Radu, Sorina Dinescu, Marieta Costache

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Simona-Rebeca IgnatDepartment of Biochemistry and Molecular Biology, University of Bucharest, 050095 Bucharest, Romania.ORCID 0000-0002-9752-6927
Andreea Daniela LazărDepartment of Biochemistry and Molecular Biology, University of Bucharest, 050095 Bucharest, Romania.ORCID 0000-0001-7185-9945
Aida ŞelaruDepartment of Biochemistry and Molecular Biology, University of Bucharest, 050095 Bucharest, Romania.
Iuliana SamoilăDepartment of Biochemistry and Molecular Biology, University of Bucharest, 050095 Bucharest, Romania.ORCID 0000-0002-8340-8460
George Mihail VlăsceanuAdvanced Polymer Materials Group, University Politehnica of Bucharest, 011061 Bucharest, Romania.ORCID 0000-0002-9876-6180
Mariana IoniţăAdvanced Polymer Materials Group, University Politehnica of Bucharest, 011061 Bucharest, Romania.
Eugen RaduMolecular Biology and Pathology Research Lab "MolImagex", University Hospital Bucharest, 050098 Bucharest, Romania.
Sorina DinescuDepartment of Biochemistry and Molecular Biology, University of Bucharest, 050095 Bucharest, Romania. sorina.dinescu@bio.unibuc.ro.ORCID 0000-0001-7196-1712
Marieta CostacheDepartment of Biochemistry and Molecular Biology, University of Bucharest, 050095 Bucharest, Romania.
University of Bucharest · ROUniversitatea Națională de Știință și Tehnologie Politehnica București · ROClinical Emergency Hospital Bucharest · RO

Funding

Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii PN-III-P1-1.2-PCCDI-2017-0782/REGMED
6 · The paper itself

Abstract

Carbon-based nanomaterials, such as graphene oxide (GO) or carbon nanotubes (CNTs) are currently used in various medical applications due to their positive influence on biocompatibility, adhesion, proliferation, and differentiation, as well as their contribution to modulating cell behavior in response to nanomaterial substrates. In this context, in this study, novel flexible membranes based on cellulose acetate (CA) enriched with CNT and GO in different percentages were tested for their versatility to be used as substrates for soft or hard tissue engineering (TE), namely, for their ability to support human adipose-derived stem cells (hASCs) adhesion during adipogenic or osteogenic differentiation. For this purpose, differentiation markers were assessed both at gene and protein levels, while histological staining was performed to show the evolution of the processes in response to CA-CNT-GO substrates. Micro-CT analysis indicated porous morphologies with open and interconnected voids. A slightly lower total porosity was obtained for the samples filled with the highest amount of GO and CNTs, but thicker walls, larger and more uniform pores were obtained, providing beneficial effects on cell behavior and increased mechanical stability. The addition of 1 wt% GO and CNT to the biocomposites enhanced hASCs adhesion and cytoskeleton formation. The evolution of both adipogenic and osteogenic differentiation processes was found to be augmented proportionally to the GO-CNT concentration. In conclusion, CA-CNT-GO biomaterials displayed good properties and versatility as platforms for cell differentiation with potential as future implantable materials in TE applications.

Indexed as

Tissue EngineeringBiocompatible MaterialsBiomarkersCell AdhesionCell Culture TechniquesCell DifferentiationCell SurvivalChemical PhenomenaGraphiteHumansMaterials TestingNanotubes, CarbonOsteogenesisPorosityTissue ScaffoldsX-Ray MicrotomographyBiocompatible MaterialsBiomarkersgraphene oxideGraphiteNanotubes, Carboncarbon nanotubescellulose acetategraphene oxidehuman adipose-derived stem cellsmicro-CT

Identifiers

PMID31398874
PMCPMC6720708
OpenAlexW2965684612

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.